Between 2013 and 2019, 3,797 patients with unresectable IIIC or stage IV melanoma were entered in the registry and died. The percentage of patients receiving a new systemic therapy within 45 and 90 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results